Arbutus reports first quarter 2025 financial results and provides corporate update

Imdusiran combination therapy has functionally cured 8 patients with chronic hepatitis b (chbv) to date, including 2 patients who received no  interferon
ABUS Ratings Summary
ABUS Quant Ranking